Antiphospholipid syndrome, also known as Hughes syndrome, is an autoimmune disorder that affects the blood's ability to clot properly. It is characterized by the presence of antiphospholipid antibodies, which mistakenly attack certain proteins in the blood, leading to an increased risk of blood clots forming in the veins and arteries. These abnormal blood clots can cause various health complications, such as deep vein thrombosis, pulmonary embolism, stroke, and recurrent miscarriages in women.
Antiphospholipid syndrome can occur as a primary condition or secondary to other autoimmune disorders, such as lupus. The exact cause of this syndrome is still unknown, but it is believed to involve a combination of genetic and environmental factors.
Diagnosis of antiphospholipid syndrome involves blood tests to detect the presence of antiphospholipid antibodies and confirm the diagnosis. Treatment typically involves the use of blood thinners (anticoagulants) to prevent blood clots from forming and reduce the risk of complications.
It is important for individuals with antiphospholipid syndrome to work closely with their healthcare providers to manage their condition effectively and minimize the risk of blood clots and associated complications.